Table 5.

Comparison of the CT findings in the immunocompromised patients and the control group

Findings		ICPs	Controls	p-value
Lesion extent		10.1	7.8	0.04
Bronchiectasis	Severity	4.5	4.3	0.71
	Extent	6.0	4.6	0.08
	Score	9.8	7.3	0.23
Small opacity
Ill-defined nodule
Cavity (−)	Extent	4.58	4.16	0.64
Cavity (+)	Extent	0.75	0.04	0.03
Well-defined nodule
Cavity (−)	Extent	1.17	1.42	0.92
Cavity (+)	Extent	0.04	0.00	0.33
Large opacity
1–2 cm
Cavity (−)	Extent	1.79	1.75	0.92
Cavity (+)	Extent	0.25	0.17	0.53
>2 cm
Cavity (−)	Extent	1.75	0.54	0.04
Cavity (+)	Extent	2.50	0.58	0.02

ICP, immunocompromised patients.